Oxymesterone
| Clinical data | |
|---|---|
| Trade names | Anamidol, Balnimax, Oranabol, Sanaboral, Theranabol, Tubil |
| Other names | Oxymestrone; Ossimesterone; Methandrostenediolone; 4-Hydroxy-17α-methyltestosterone; 17α-Methylandrost-4-en-4,17β-diol-3-one; 4,17β-Dihydroxy-17α-methylandrost-4-en-3-one |
| Routes of administration | By mouth |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.005.134 |
| Chemical and physical data | |
| Formula | C20H30O3 |
| Molar mass | 318.457 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
Oxymesterone (INN, BAN) (brand names Anamidol, Balnimax, Oranabol, Sanaboral, Theranabol, Tubil), also known as methandrostenediolone, as well as 4-hydroxy-17α-methyltestosterone or 17α-methylandrost-4-en-4,17β-diol-3-one, is an orally active anabolic-androgenic steroid (AAS). It was known by 1960.